Most products fail before the first line of code is written. Strategy is what changes that.

We take products from commercial idea to market-ready reality — with the strategic rigour, technical architecture and product discipline that ensure you build the right thing before you invest in building it well.

Growth-stage founders with a product vision, pharmaceutical directors with an operational tool to build, and clinical entrepreneurs who need a senior engineering partner — not a development shop that executes briefs without challenging them. We start with the problem. We design for scale from the first sprint. We ship to real users early and iterate from evidence.

Website Audit

PERFORMANCE

ACCESSIBILITY

SEO

BEST PRACTICES

The question is never whether to build. It is whether to build this.

The most common product failure mode is not a technology failure. It is a strategy failure — a product built on assumptions nobody tested, for users nobody interviewed, solving a problem that was not actually the problem. Discovery is not a phase of the project that adds time. It is the insurance policy against spending the next 18 months building the wrong product and the next 18 months after that rebuilding it.

9/10

Product failures trace back to a problem-solution mismatch that a rigorous discovery process would have identified — before a line of production code was written.

18 MO

Average time lost when a growth-stage product reaches the market and discovers the core assumption was wrong — the rebuild cycle that follows.

6WK

Discovery investment — the time it takes us to validate your core assumptions and define the product brief with enough precision to build from it confidently.

Four patterns that repeat. One preventable cause.

These are the failure modes we encounter consistently in product engagements — from HealthTech founders to pharmaceutical operations directors. The cause is almost always the same: build before strategy.

Building the Wrong Thing Because Discovery Was Skipped

The pressure to ship is real. The cost of shipping the wrong product is greater. Organisations that bypass discovery do not move faster — they arrive sooner at the wrong destination. A product built on assumptions that nobody tested will eventually need to be rebuilt. The only question is how much runway you spend before you discover that.

Running Out of Runway Before Product-Market Fit

The runway-to-fit problem is almost always a prioritisation problem. Features are added because someone asked for them, not because evidence showed they would move the metric that matters. The backlog grows. The build time extends. The question of whether the product is actually working gets harder to answer the more complicated the product becomes.

Technical Debt That Makes Every Feature a Project

Architecture decisions made in the first six months of a product’s life determine the cost of every change for the next six years. Codebases built under pressure, without architecture review, accumulate technical debt that eventually makes simple features expensive and complex features impossible. The engineering team spends more time maintaining the past than building the future.

No Product Strategy — Just a Backlog of Opinions

A product backlog assembled from stakeholder requests, sales feedback and customer complaints is not a product strategy. It is a list of opinions with no commercial weighting. Without a clear product vision, defined success criteria and a prioritisation framework grounded in user evidence and commercial impact, product teams build busy — not strategically.

Five stages.One product journey.

Product development is not a single engagement. It is a sequence of distinct disciplines — each one building on the last. We lead every stage, or we enter where you need us and take it from there.

Product Strategy & Discovery

The most valuable work we do happens before any design or code. We run structured discovery programmes — stakeholder interviews, user research, market analysis, technical feasibility and commercial validation — that answer the most important question in product development: is this the right thing to build? Discovery is not a delay. It is the insurance policy against spending six months building the wrong product.

Validated problem definition and user research synthesis
Competitive landscape analysis and market positioning
Product vision, principles and commercial success criteria
Build/buy/partner recommendations with commercial rationale

MVP Architecture & Design

The architecture decisions made in the first sprint determine what is possible in the tenth. We design product architecture — data models, API structures, integration points, scalability considerations — with the product’s three-year trajectory in mind, not just the six-week MVP. MVP does not mean minimal thinking. It means minimum feature set with maximum strategic intent.

Product architecture and technical design documentation
User journey mapping, wireframes and high-fidelity UI
API design and third-party integration specifications
Sprint plan, resource allocation and definition of done

Agile Build & Iteration

We build in two-week sprints with working, testable software at the end of every cycle. Real users interact with real software from Sprint 3 — not at the end. Feedback from those interactions shapes the next sprint. This is not agile as a process label. It is agile as a commercial discipline: the fastest route to knowing whether what you built solves the problem it was designed to solve.

Working software shipped every two weeks
User testing sessions at the end of every sprint
Sprint retrospective and velocity reporting for stakeholders
Product backlog prioritised by commercial impact and evidence
Performance monitoring and error tracking from day one

Growth Engineering & Optimisation

Getting to market is the start. Growing from it requires a different discipline. We apply product analytics, conversion optimisation, A/B testing and performance engineering to identify where the product is and is not delivering the commercial outcome it was designed to produce — and make the changes that improve it. The product that ships on launch day is never the best version of the product.

Product analytics implementation and funnel analysis
A/B testing framework and experimentation programme
Conversion pathway optimisation and friction reduction
Retention and engagement feature development
Monthly commercial performance reporting

Scale Architecture

The infrastructure decisions that support 1,000 users often break at 50,000. We design and implement the architectural changes — database optimisation, caching layers, background job infrastructure, CDN configuration, monitoring and alerting — that allow your product to handle the growth you are working toward without emergency rewrites under pressure. Scale is a design decision. It should not arrive as a crisis.

Infrastructure audit and scale readiness assessment
Database optimisation and query performance review
Caching, CDN and performance infrastructure implementation
Monitoring, alerting and incident response framework
Technical debt assessment and remediation roadmap

What separates this engagement from a development shop

Strategy Before Code. Without Exception.

We will not begin a build engagement without a validated product brief. If we cannot agree on what commercial success looks like before we start, we should not start. This is not a process preference — it is a position grounded in how product failures actually happen.

Senior Product Leadership Throughout

Product strategy is done by senior practitioners — not documented by a junior analyst and handed to a development team. The person who runs your discovery session is the person who architects your product and reviews every sprint delivery.

Commercial Outcome Accountability

Feature delivery is not success. User adoption, retention, and the commercial metric the product was designed to move are success. We define those metrics before the first sprint and measure against them throughout the engagement.

Healthcare & Pharma Product Expertise

We understand the specific regulatory, compliance and user trust requirements of building products in clinical and pharmaceutical environments. WCAG, GDPR, clinical governance, MHRA awareness — these are architectural requirements in our process, not afterthought additions.

Clean Handover. No Lock-In.

You own the product, the codebase, the architecture documentation, and the product decisions that shaped it. We build for clean handover — so future engineers can maintain and extend the product without requiring our continued involvement.

Who We Build Products With

We do our best product work with founders and operators who are prepared to invest in strategy before they invest in engineering — and who measure product success in commercial outcomes, not feature count.

Growth-stage founders with a validated commercial idea and available runway to build it properly
HealthTech and clinical entrepreneurs building products in regulated environments for the first time
Pharmaceutical directors with an operational product to build that existing vendors cannot accommodate
Series A-stage businesses whose product architecture is constraining growth and needs structural remediation
Founders who have built a v1 with another agency and need a senior partner to take it where it needs to go

Also in Digital Experiences & Products — Pillar 01